‘‘(C) provide assurance that enrollees will 
have baseline and ongoing medical data col-
lected, including data related to pulmonary 
function and skin or in vitro testing for sen-
sitization to allergies; 
‘‘(D) propose novel approaches to studying 
the gene-environment interaction of the patients 
and have the capacity to engage in such data 
collection, or partner with an institution with 
such a capacity; 
‘‘(E) contain assurances that the applicant 
will communicate in a manner designed to pre-
serve patient confidentiality, with at least 1 of 
the asthma clinical centers of the National In-
stitutes of Health; and 
‘‘(F) provide assurances that the applicant 
can effectively coordinate care between physi-
cians, including asthma specialists, nurses, al-
lied health professionals, community health 
workers, nonprofit organizations, and the other 
entities responsible for implementing the pilot 
project involved. 
‘‘(3) COLLABORATION
WITH
LOCAL
INSTITU-
TIONS.—An eligible entity receiving a grant under 
this section is encouraged to— 
VerDate Nov 24 2008 
08:19 Oct 08, 2009
Jkt 089200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H3754.IH
H3754
CPrice-Sewell on DSKGBLS3C1PROD with BILLS
‘‘(A) collaborate with 1 or more Head 
Start programs to identify children and families 
with asthma within the geographic area of the 
applicant; 
‘‘(B) collaborate with local school districts 
to recruit children with physician-diagnosed 
asthma; and 
‘‘(C) partner with local, community-based 
nonprofit organizations to identify children and 
families with asthma within the geographic area 
of the entity. 
‘‘(e) USE OF FUNDS.— 
‘‘(1) IN GENERAL.—An eligible entity shall use 
amounts received under a grant under this section to 
carry out the purpose described in subsection (a), in-
cluding— 
‘‘(A) conducting an assessment of the pa-
tients served to determine possible contributors 
to asthma exacerbations in the indoor and out-
door environments, including exposure to diesel 
and other particles, ozone and other gases, gas-
eous pollutants and allergens, mold, chemicals 
found in the home or workplace, and other in-
door pollutants; 
VerDate Nov 24 2008 
08:19 Oct 08, 2009
Jkt 089200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H3754.IH
H3754
CPrice-Sewell on DSKGBLS3C1PROD with BILLS
‘‘(B) implementing interventions regarding 
indoor and outdoor environments to reduce the 
severity and persistence of asthma; 
‘‘(C) developing and maintaining question-
naires completed by the patients, or the parents 
or guardians of the patients, regarding their re-
spective occupations and personal exposure his-
tory, in order to increase the understanding of 
factors that contribute to asthma prevalence; 
and 
‘‘(D) conducting other research as des-
ignated by the Director of the National Insti-
tutes of Health, particularly in areas that will 
advance knowledge of the factors that con-
tribute to asthma. 
‘‘(2) RESEARCH OF SIGNIFICANT INTEREST.— 
An eligible entity receiving a grant under this sec-
tion is encouraged to conduct research under this 
section on the interactions between environmental 
exposures and genetic susceptibilities that contribute 
to the development or exacerbation of asthma. 
‘‘(f) PROTECTION OF INFORMATION.—The Secretary 
shall ensure the implementation of protections of indi-
vidual health privacy under this section consistent with the 
regulations promulgated under section 264(c) of the 
VerDate Nov 24 2008 
08:19 Oct 08, 2009
Jkt 089200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H3754.IH
H3754
CPrice-Sewell on DSKGBLS3C1PROD with BILLS
Health Insurance Portability and Accountability Act of 
1996. 
‘‘(g) REPORT.—The Secretary shall submit a report 
to the Congress on the success of and the next steps re-
sulting from the pilot projects funded under this section 
not later than 5 years after the date of the enactment of 
this section. 
‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary for each of fiscal years 2010 through 2014 to 
carry out this section.’’. 
SEC. 4. NATIONAL ASTHMA EDUCATION AND PREVENTION 
PROGRAM OF THE NATIONAL HEART, LUNG, 
AND BLOOD INSTITUTE. 
Part C of title IV of the Public Health Service Act 
(42 U.S.C. 285 et seq.) is amended by inserting after sec-
tion 424C the following: 
‘‘SEC. 424D. EXPANSION OF THE NATIONAL ASTHMA EDU-
CATION AND PREVENTION PROGRAM. 
‘‘(a) DEVELOPMENT OF A NATIONAL ASTHMA AC-
TION PLAN.— 
‘‘(1) IN GENERAL.—In addition to any other 
authorization of appropriation available to the Na-
tional Heart, Lung, and Blood Institute for the pur-
pose of carrying out the National Asthma Education 
VerDate Nov 24 2008 
08:19 Oct 08, 2009
Jkt 089200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H3754.IH
H3754
CPrice-Sewell on DSKGBLS3C1PROD with BILLS
and Prevention Program (referred to in this section 
as the ‘program’), there is authorized to be appro-
priated to such Institute such sums as may be nec-
essary for each of fiscal years 2010 through 2014 to 
develop a National Asthma Action Plan. 
‘‘(2) USE OF APPROPRIATIONS.—The amounts 
appropriated pursuant to paragraph (1) shall be 
used to fund the report by the program described 
under subsection (b). 
‘‘(b) REPORT TO CONGRESS.— 
‘‘(1) IN
GENERAL.—Not later than 2 years 
after the date of the enactment of the Family Asth-
ma Act, the program shall, in consultation with pa-
tient groups, nonprofit organizations, medical soci-
eties, and other relevant governmental and non-
governmental entities that participate in the pro-
gram, submit to the Congress a report that— 
‘‘(A) catalogs, with respect to asthma pre-
vention, management, and surveillance— 
‘‘(i) the activities of the Federal Gov-
ernment, including an assessment of the 
progress of the Federal Government and 
States, with respect to achieving the goals 
of the Healthy People 2020 initiative; and 
VerDate Nov 24 2008 
08:19 Oct 08, 2009
Jkt 089200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H3754.IH
H3754
CPrice-Sewell on DSKGBLS3C1PROD with BILLS